I am pleased to share our recent work published in Nature Cancer: nature.com/articles/s4301…

and Nature Genetics: nature.com/articles/s4158…

Extreme gratitude to my colleagues who contributed to this work @lfspurr Ralph Weichselbaum Everett Vokes Mengjie Chen Jyoti D Patel Max Diehn, MD/PhD Docace911 and funding from Ludwig Cancer LUNGevity Foundation UChicagoCancerCenter UChicago Medicine University of Chicago Radiation Oncology

cancercommunity.nature.com/posts/highly-a…

📣 OUT NOW Nature Genetics 📰 Tumor aneuploidy predicts survival following immunotherapy across multiple cancers 🧑🏿‍🤝‍🧑🏽 Sean Pitroda, M.D. and team 👇🏽 go.nature.com/3gLfoSk

Remember the NULL: fun to respond to this commentary with my good colleague Julia White and in my role as Hand to the King Wendy Woodward MDPhD NRG Oncology UChicago Medicine Breast Cancer Program Reply to J. Widder ascopubs.org/doi/full/10.12…

Two fantastic papers published this week in Nature Cancer & Nature Genetics by Sean Pitroda, M.D. and his team. This work demonstrates the need for concurrent radiation and immunotherapy for certain mNSCLC patients. UChicago Medicine UChicagoCancerCenter @lfspurr ow.ly/qQTf50LRwKU

📢Excited that our new IIT evaluating ctDNA response-adaptive IO-based therapy in #headandneckcancer now open to accrual UChicagoCancerCenter! Thank you to Cancer Research Foundation for the support! 🧑‍🔬🔬clinicaltrials.gov/ct2/show/NCT05…

Dr. Julia White will discuss the NRG-BR007 DEBRA Trial today during a poster presentation at #SABCS22. This #clinicaltrial is looking at reducing the use of breast radiation after lumpectomy for people with low-risk, early-stage #breastcancer. Learn more: nrgoncology.org/DEBRA-Trial

One day we will learn that overworking people is not beneficial. We will fix being short-staffed before it becomes an unsustainable problem. Until then, my vacation is worth gold.

Just tested out #ChatGPT’s ability to write a letter to an insurance company with citations supporting RT for oligomets. It took ~ten seconds 🤯 #radonc

With Docace911 we present our dogma challenging #RadOnc & #immunotherapy manuscript showing safety & prelim efficacy of partial tumor irradiation with anti-PD1. In contrast w aBscopal, we suggest an aDscopal effect where IO enhances local #radiation. jci.org/articles/view/…

Jason Luke, MD, FACP Docace911 UPMC Hillman Cancer Center PittDeptofMed UChicagoCancerCenter Ludwig Cancer Benjamin Onderdonk Amer. Radium Society ASTRO Journal of Clinical Investigation Mark Korpics There definitely is a bad scopal in some cases! Coming soon, May 25! This is great work however, when did parameters to see who will get immune stimulation or inhibitors

Celebrating our wonderful clinical trial staff who make cutting edge research possible and accessible to our patients !! University of Chicago Radiation Oncology UChicagoCancerCenter Docace911 Jared Hara Rohan Katipally

Wonderful night celebrating our talented residents at our end of year graduation dinner. Looking forward to following the careers of a truly amazing class Jared Hara Rohan Katipally Peter Ferjančič University of Chicago Radiation Oncology

YTHDF2 inhibition potentiates radiotherapy antitumor efficacy - ScienceDirect Congrats ⁦Ralph Weichselbaum⁩ ⁦Docace911⁩ and team!! #radonc sciencedirect.com/science/articl…

In our #AskAScientist series on promising areas of cancer research for those starting their scientific careers, Ludwig UChicago Medicine’s Ralph Weichselbaum highlights bioinformatic analysis as a key skill for future researchers.

Happy to present our work led by excellent PGY4 Connor Lynch on a pooled analysis of liver SBRT and immunotherapy in patients with polymetastatic disease treated on three phase 1 trials UChicagoCancerCenter. redjournal.org/article/S0360-…  We show that:

Congrats!!!!!!!!!!!!!!!!!!!!!!!!!